MARKETSnap
  • Gainers &
    Losers
  • Most Active &
    More
  • 52-Week
    High/Low
  • P/E
    Ratios
    • Large Caps
    • Absolute
    • Total Market PE
  • Stocks
    Performance
    • Large Caps
    • Absolute
  • Industries
    Performance
    • Industry
    • Sector
  • Dividends
  • 📅 Calendar
    • Earnings Calendar
    • Dividends Calendar
    • Economics Calendar
  • 🔧 Tools
    • 💰 Intrinsic Value Calculator
    • 📈 Compounding Calculator
    • 🤖 Stock Pick Screener
  • More
    • Investment Compounding Calculator
    • Commodities
    • Currencies
    • Economic Indicators
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
CVRX stock logo

CVRX

CVRx, Inc.

$5.2
-0.2
 (-3.7%)
Exchange:  NASDAQ
Market Cap:  137.987M
Shares Outstanding:  387083
Delayed data
Calculate CVRX Intrinsic Value
5-year outlook →
Overview
Earnings
Financials
Valuation
Chart

About The Company

Sector:  Healthcare
Industry:  Medical – Devices
   
CEO:  Kevin Hykes
Full Time Employees:  206
Address: 
9201 West Broadway Avenue
Minneapolis
MN
55445
US
Website:  https://www.cvrx.com
CVRx, Inc. is a commercial-stage medical technology company focused on innovating, producing, and bringing to market neuromodulation solutions designed for individuals battling cardiovascular diseases. Its principal offering, Barostim, is an advanced neuromodulation device specifically indicated to ameliorate symptoms for patients diagnosed with heart failure characterized by reduced ejection fraction, often referred to as systolic heart failure. The company employs a diverse distribution strategy, leveraging its internal sales force, alongside sales agents and independent distributors, to reach markets across the United States, Germany, the wider European continent, and other global territories. Incorporated in 2000, CVRx, Inc. is headquartered in Minneapolis, Minnesota.

Click to read more…

Revenue Segmentation

MARKETSnap

Log in to continue

Log in to see the complete revenue and geographic breakdown.

Login — it's free

EPS

Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.

Log in to continue

Log in for the full EPS chart and links to analyst estimates.

Login — it's free
View full analyst estimates

Earnings Call

Full text

Earnings transcript

Read the complete earnings call transcript.

AI summary

Key takeaways

Short, structured highlights from the call so you can focus on what matters.

2026/05/11 — Q1 quarter 2026

Log in to continue

Log in to read the full transcript and AI-generated earnings summaries.

Login — it's free
Income Statement
Balance Sheet
Cash Flow Statement
Analyst Estimates

Income Statement

Year202320242025
Revenue39,29551,29256,651
Gross Profit33,03942,95848,340
EBITDA-38,731-54,894-46,741
Operating Income-43,103-59,490-51,265
Net Income-41,199-59,965-53,306

Log in to continue

Log in to see the income statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Balance Sheet

Year202320242025
Total Assets115,229133,414104,794
Total Liabilities39,28262,35965,470
Total Stockholders Equity75,94771,05539,324
Total Debt30,61350,43250,790
Cash and Cash Equivalents90,569105,93375,708

Log in to continue

Log in to see the balance sheet and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Cash Flow Statement

Year202320242025
Operating Cash Flow-39,021-39,144-40,170
Capital Expenditure-591-1,361-580
Free Cash Flow-39,612-40,505-40,750
Net Income-41,199-59,965-53,306
Net Change in Cash-15,62515,364-30,225

Log in to continue

Log in to see the cash flow statement and 10 historical years.

Login — it's free

(* All numbers are in thousands)

Analyst Estimates

Fiscal Year2030Full AccessFull AccessFull AccessFull Access
Estimated Revenue (Low)131,415.228Full AccessFull AccessFull AccessFull Access
Estimated Revenue (High)137,288.589Full AccessFull AccessFull AccessFull Access
Estimated Revenue (Avg)133,800Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (Low)-132,091.290Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (High)-126,440.276Full AccessFull AccessFull AccessFull Access
Estimated Ebitda (Avg)-128,734.768Full AccessFull AccessFull AccessFull Access
Estimated Net Income (Low)-32,632.233Full AccessFull AccessFull AccessFull Access
Estimated Net Income (High)-30,831.083Full AccessFull AccessFull AccessFull Access
Estimated Net Income (Avg)-31,562.499Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (Low)245,704.293Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (High)256,685.593Full AccessFull AccessFull AccessFull Access
Estimated SGA Expense (Avg)250,163.052Full AccessFull AccessFull AccessFull Access
Estimated EPS (Avg)-1.210Full AccessFull AccessFull AccessFull Access
Estimated EPS (High)-1.180Full AccessFull AccessFull AccessFull Access
Estimated EPS (Low)-1.250Full AccessFull AccessFull AccessFull Access
Number of Analysts (Estimated Revenue)3Full AccessFull AccessFull AccessFull Access
Number of Analysts (Estimated EPS)2Full AccessFull AccessFull AccessFull Access

Log in to continue

Log in and subscribe to Full Access to see up to 5 years of analyst estimates.

Login — it's free

(* All numbers are in thousands)

Current Key Metrics

?Revenue
 (TTM)
: 
51.292M  ?P/S
 (TTM)
: 
2.42
?Net Income
 (TTM)
: 
-59965000  ?P/E
 (TTM)
: 
-2.69
?Enterprise Value
 (TTM)
: 
129.494M  ?EV/FCF
 (TTM)
: 
-3.22
?Dividend Yield
 (TTM)
: 
0  ?Payout Ratio
 (TTM)
: 
0
?ROE
 (TTM)
: 
-1.21  ?ROIC
 (TTM)
: 
-0.55
?Net Debt
 (TTM)
: 
-55501000  ?Debt/Equity
 (TTM)
: 
2.03
?P/B
 (TTM)
: 
4.87  ?Current Ratio
 (TTM)
: 
10.2

Log in to continue

Log in to see all key valuation metrics and ratios for this symbol.

Login — it's free

Forward P/E Ratios

?

Forward P/E (Avg EPS estimate) — log in with Full Access for high/low estimates and the interactive table.

Forward P/E 1YFull AccessFull AccessFull AccessFull Access
N/AFull AccessFull AccessFull AccessFull Access

Log in to continue

Log in with Full Access for forward P/E high/low estimates and the full multi-year table.

Login — it's free

SWOT Analysis

🔒 You are currently logged out

Login

It's free

At what price to buy it? -
Intrinsic Value Calculator

This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.

[intrinsic_calculator]

Common questions about CVRX valuation

Is CVRx, Inc. (CVRX) overvalued or undervalued right now?

MARKETSnap estimates intrinsic value for CVRx, Inc. (CVRX) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.

Is CVRX a buy, hold, or sell for long-term investors?

MARKETSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether CVRX trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.

What is CVRX’s P/E ratio?

You can see CVRX’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.

How is intrinsic value calculated for CVRX?

MARKETSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MARKETSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.

Is CVRX a good long-term investment?

Whether CVRX fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MARKETSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.

CVRX

1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.

Daily snapshot

-3.7
MARKETSnap

Trading Metrics:

Open: 5.25   Previous Close: 5.4
Day Low: 4.83   Day High: 5.41
Year Low: 4.37   Year High: 11.3
Price Avg 50: 7.01   Price Avg 200: 7.83
Volume: 398377   Average Volume: 288834

Log in to continue

Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.

Login — it's free
Could not create stock discussion for CVRX

Relevant news

CVRx to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
27-05-2026 16:30
CVRx to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
CVRx to Present at the William Blair 46th Annual Growth Stock Conference
20-05-2026 16:30
CVRx to Present at the William Blair 46th Annual Growth Stock Conference
CVRx Stock Up on Humana's Medicare Coverage for Barostim Therapy
18-05-2026 13:36
CVRx Stock Up on Humana's Medicare Coverage for Barostim Therapy
CVRx Announces First Patient Enrollment in BENEFIT-HF, a Landmark Heart Failure Trial Evaluating Barostim in Significantly Expanded Population
04-05-2026 16:30
CVRx Announces First Patient Enrollment in BENEFIT-HF, a Landmark Heart Failure Trial Evaluating Barostim in Significantly Expanded Population
CVRx to Report First Quarter 2026 Financial and Operating Results and Host Conference Call on May 11, 2026
27-04-2026 16:30
CVRx to Report First Quarter 2026 Financial and Operating Results and Host Conference Call on May 11, 2026
CVRx Announces Nomination of Michael Dale for Election to the Board of Directors
20-04-2026 16:30
CVRx Announces Nomination of Michael Dale for Election to the Board of Directors

DISCLAIMER: The stock market data provided on this website is for informational purposes only and is not intended for trading purposes. While we strive to provide accurate and timely information, we cannot guarantee that the information is accurate at the moment it is received or that it will continue to be accurate in the future. We are not responsible for any actions taken based on the information provided on this website. Always consult with a licensed financial professional before making any investment decisions.
Terms of Service

Copyright © 2025 MarketSnap. All rights reserved.

Contact Us

Privacy Policy

Cookie Policy

Terms of Service

Hover Image
MARKETSnap

Market

🇺🇸 United States

Language

  • Gainers & Losers
  • Most Active & More
  • 52-Week High/Low
  • Dividends
    • Large Caps
    • Absolute
    • Total Market PE
    • Large Caps
    • Absolute
    • Industry
    • Sector
    • Earnings Calendar
    • Dividends Calendar
    • Economics Calendar
  • 💰 Stock intrinsic value Calculator
  • 📈 Investment Compounding Calculator
  • 🤖 Stock Pick Screener
  • 📋 Watchlist & Portfolio
    • Commodities
    • Currencies
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
  • Nexus
  • Login Login
  • Profile Profile
  • Watchlists Watchlists
  • My Valuations My Valuations
  • Settings Settings

Media

Watch Listen Read